BlueCrest Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,441
Closed -$265K 396
2019
Q1
$265K Buy
+20,441
New +$358K 0.01% 776
2018
Q4
Sell
-11,361
Closed -$447K 825
2018
Q3
$447K Buy
+11,361
New +$512K 0.01% 812
2018
Q1
Sell
-9,384
Closed -$739K 1456
2017
Q4
$739K Buy
+9,384
New +$757K 0.02% 439
2017
Q2
Sell
-2,848
Closed -$207K 887
2017
Q1
$207K Buy
+2,848
New +$187K 0.01% 614

Other funds holding ADNT

BlueCrest Capital Management's ADNT Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Adient (ADNT) in Q2 2019, closing a stake of 20,441 shares — an estimated $265K sold.

BlueCrest Capital Management first reported a position in ADNT in Q1 2017 and held it in 4 quarters. The position peaked at $739K in Q4 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 20,441 Adient shares in Q2 2019, an estimated $265K.
  • BlueCrest Capital Management first reported a position in Adient in Q1 2017 and held it in 4 quarters.
  • BlueCrest Capital Management's Adient position peaked at $739K in Q4 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.